AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Amarglim Plus 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

ASV Laboratories India Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Amarglim Plus 1mg/500mg Tablet

Diabexe Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; premature discontinuation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are vital for prevention. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Amarglim Plus 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Amarglim Plus 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Amarglim Plus 1mg/500mg Tablets. Ingest each tablet whole; do not break, crush, or chew. Consume with a meal.

Common Side effects of Amarglim Plus 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Amarglim Plus 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Amarglim Plus 1mg/500mg tablets should be administered with a meal.

How Amarglim Plus 1mg/500mg Tablet works:

Amarglim Plus, a 1mg/500mg tablet, unites glimepiride and metformin to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Amarglim Plus 1mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Amarglim Plus 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Lactation and Amarglim Plus 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving should such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Amarglim Plus 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Amarglim Plus 1mg/500mg tablets. Physician consultation is advised. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Amarglim Plus 1mg/500mg tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Amarglim Plus 1mg/500mg Tablet :

Should you forget to take your Amarglim Plus 1mg/500mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Amarglim Plus 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Amarglim Plus 1mg/500mg Tablet

Store the medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any leftover medication and ensure it remains inaccessible to children, pets, and others.
Indeed, Amarglim Plus 1mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also referred to as Metformin-associated lactic acidosis (MALA). While uncommon, this adverse reaction linked to metformin makes the medication unsafe for individuals with pre-existing kidney problems, the elderly, or those who consume substantial alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, queasiness, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Amarglim Plus 1mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Amarglim Plus 1mg/500mg Tablet, manage type 2 diabetes mellitus (DM) in adults. This dual-action therapy enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin concurrently decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for treating type 1 DM.
Taking Amarglim Plus 1mg/500mg tablets may result in common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal pain, loose stools, and headaches. Rare but potentially serious side effects include lactic acidosis. Prolonged use might also cause a Vitamin B12 deficiency.
Prolonged use of Amarglim Plus 1mg/500mg Tablets can indeed lead to Vitamin B12 deficiency. This is due to the medication's interference with Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, general weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Indeed, Amarglim Plus 1mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Amarglim Plus 1mg/500mg tablets with alcohol is inadvisable due to the risk of dangerously low blood sugar (hypoglycemia). Concurrent use also elevates the likelihood of lactic acidosis.
Amarglim Plus 1mg/500mg T...
30
MRP 37
17% off